Atlas Trials

Safety and Immunogenicity of the Inactivated Koçak-19 Inaktif Adjuvanlı COVID-19 Vaccine Compared to Placebo

Clinical trial NCT04838080 · UNKNOWN

Trial details

NCT number
NCT04838080
Sponsor
Kocak Farma
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
COVID-19 Vaccine
Start date
2021-03-19
Primary completion
2021-06-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.